Literature DB >> 18831801

Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments.

Christian Bottomley1, Valerie Isham, Richard C Collins, Maria-Gloria Basáñez.   

Abstract

Regular distribution of ivermectin reduces onchocerciasis transmission and morbidity by killing, within humans, the microfilarial stage of the parasite (microfilaricidal effect). In addition, ivermectin exerts a so-called embryostatic effect by which microfilarial production by the adult female worm becomes suppressed during a number of weeks after treatment. To assess the overall effect of ivermectin on onchocerciasis transmission and evaluate the likelihood of local elimination of the infection it is important to estimate the magnitude of the anti-fertility effect over the course of a treatment programme. Estimates of the effect of repeated drug treatments on the production of microfilariae by adult Onchocerca volvulus were obtained by developing a model that was fitted to data collected from three hyperendemic communities in Guatemala, where eligible residents received ivermectin twice per year for two and a half years. The data consist of microfilarial load measurements in the skin, collected just before each six-monthly treatment during the programme. The model that is developed describes the dynamics of an individual host's expected microfilarial load over the 30-month study period. We adopt a Bayesian approach and use Markov chain Monte Carlo (McMC) techniques to fit the model to the data. Combining estimates from the three villages, average microfilarial production in the first six months post-treatment was reduced by ~64% of its pre-treatment level, regardless of values chosen for the pre-ivermectin fertility rate within plausible ranges. Increased adult worm death rate after treatment (to mimic removal of macrofilariae via nodulectomy during the programme) resulted in a smaller estimated magnitude of the embryostatic effect (rate of microfilarial production was reduced by ~58% of pre-ivermectin value). After subsequent treatments, the rate of microfilarial production appeared to be similarly decreased. The data and analyses therefore do not support the hypothesis of a cumulative effect of multiple ivermectin treatments on microfilarial production by female worms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18831801     DOI: 10.1017/S0031182008000425

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  16 in total

1.  Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.

Authors:  Moses N Katabarwa; Albert Eyamba; Philippe Nwane; Peter Enyong; Souleymanou Yaya; Jean Baldiagaï; Théodore Kambaba Madi; Abdoulaye Yougouda; Gervais Ondobo Andze; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin.

Authors:  Moses N Katabarwa; Tom Lakwo; Peace Habomugisha; Stella Agunyo; Edson Byamukama; David Oguttu; Ephraim Tukesiga; Dickson Unoba; Patrick Dramuke; Ambrose Onapa; Edridah M Tukahebwa; Dennis Lwamafa; Frank Walsh; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2013-05-20       Impact factor: 2.345

3.  Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.

Authors:  Thomas S Churcher; Sébastien D S Pion; Mike Y Osei-Atweneboana; Roger K Prichard; Kwablah Awadzi; Michel Boussinesq; Richard C Collins; James A Whitworth; María-Gloria Basáñez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

4.  Successful treatment of Brugia pahangi in naturally infected cats with ivermectin.

Authors:  Piyanan Taweethavonsawat; Sudchit Chungpivat
Journal:  Korean J Parasitol       Date:  2013-12-31       Impact factor: 1.341

5.  Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.

Authors:  Mike Y Osei-Atweneboana; Kwablah Awadzi; Simon K Attah; Daniel A Boakye; John O Gyapong; Roger K Prichard
Journal:  PLoS Negl Trop Dis       Date:  2011-03-29

6.  Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.

Authors:  Lamine Diawara; Mamadou O Traoré; Alioune Badji; Yiriba Bissan; Konimba Doumbia; Soula F Goita; Lassana Konaté; Kalifa Mounkoro; Moussa D Sarr; Amadou F Seck; Laurent Toé; Seyni Tourée; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21

7.  Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Authors:  Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

8.  Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Authors:  Sébastien D S Pion; Hugues C Nana-Djeunga; Joseph Kamgno; Nicholas Tendongfor; Samuel Wanji; Flobert Njiokou; Roger K Prichard; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

9.  African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.

Authors:  Luc E Coffeng; Wilma A Stolk; Honorat G M Zouré; J Lennert Veerman; Koffi B Agblewonu; Michele E Murdoch; Mounkaila Noma; Grace Fobi; Jan Hendrik Richardus; Donald A P Bundy; Dik Habbema; Sake J de Vlas; Uche V Amazigo
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31

10.  Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of cameroon.

Authors:  Moses N Katabarwa; Albert Eyamba; Philippe Nwane; Peter Enyong; Joseph Kamgno; Thomas Kueté; Souleymanou Yaya; Rosalie Aboutou; Léonard Mukenge; Claude Kafando; Coulibaly Siaka; Salifou Mkpouwoueiko; Demanga Ngangue; Benjamin Didier Biholong; Gervais Ondobo Andze
Journal:  J Parasitol Res       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.